Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 934757, 8 pages
http://dx.doi.org/10.1155/2011/934757
Research Article

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

Neogenix Oncology, Inc., 9700 Great Seneca Highway, Suite 262, Rockville, MD 20850, USA

Received 24 September 2010; Accepted 16 November 2010

Academic Editor: Kwong Yok Tsang

Copyright © 2011 Janos Luka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Janos Luka, Philip M. Arlen, and Andrew Bristol, “Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 934757, 8 pages, 2011. https://doi.org/10.1155/2011/934757.